[The efficacy of osteoquin in treating the postmenopausal and senile forms of osteoporosis].
A 1-year administration of osteoquine (7-isopropoxyisoflavon) to 20 patients with postmenopausal and senile systemic osteoporosis has shown a pronounced analgetic effect of this drug, its ability to stop the loss of and in some instances to increase bone mass, to stimulate osteogenesis.
Rodionova
S S
SS
D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects; D016723:Bone Remodeling / Q000187:drug effects; D005260:Female; D006801:Humans; D007529:Isoflavones / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D015663:Osteoporosis, Postmenopausal / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011859:Radiography
D000700:Analgesics; D007529:Isoflavones; C018986:ipriflavone
Effektivnost' osteokhina pri lechenii postmenopauzal 'noĭ i senil'noĭ formy osteoporoza.